Bernstein Maintains Market Perform on Allogene Therapeutics, Raises Price Target to $3.85

Benzinga Newsdesk www.benzinga.com Positive 81.7%

Neg 0% Neu 0% Pos 81.7%

Bernstein analyst William Pickering maintains Allogene Therapeutics (NASDAQ:ALLO) with a Market Perform and raises the price target from $1.6 to $3.85.